Lifevantage Corporation Total Liabilities
Lifevantage Corporation total liabilities. Based on the latest financial reports, Lifevantage Corporation (LFVN) has total liabilities worth $28.52 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Lifevantage Corporation (LFVN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Lifevantage Corporation (1997–2026)
Total liabilities of Lifevantage Corporation from 1997 to 2026. This chart illustrates how Lifevantage Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore Lifevantage Corporation long-term investment intensity to see how much of total assets are deployed in long-term investments.
Lifevantage Corporation Competitors by Total Liabilities
The table below lists competitors of Lifevantage Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Technology & Telecommunication
NASDAQ:TETE
|
USA | $10.52 Million |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IS:PENTA
|
Turkey | TL8.70 Billion |
|
Tecnotree Oyj
HE:TEM1V
|
Finland | €42.90 Million |
|
Hai Kwang Enterprise Corp
TW:2038
|
Taiwan | NT$5.04 Billion |
|
Kingfisher PLC
LSE:KGF
|
UK | GBX5.31 Billion |
|
ABOV Semiconductor Co. Ltd
KQ:102120
|
Korea | ₩132.48 Billion |
|
Pc Iletisim ve Medya Hizmetleri Sanayi Ticaret AS
IS:PCILT
|
Turkey | TL2.97 Billion |
|
Sanurhasta Mitra PT
JK:MINA
|
Indonesia | Rp13.06 Billion |
Liability Composition Analysis (1997–2026)
This chart breaks down Lifevantage Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Lifevantage Corporation.
Liquidity & Leverage Metrics
Lifevantage Corporation Total Liabilities Ratios Explained
Lifevantage Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifevantage Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifevantage Corporation (1997–2026)
The table below shows the annual total liabilities of Lifevantage Corporation from 1997 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | $28.52 Million | -23.57% |
| 2025-06-30 | $37.32 Million | +8.77% |
| 2024-06-30 | $34.31 Million | +9.00% |
| 2023-06-30 | $31.47 Million | -19.69% |
| 2022-06-30 | $39.19 Million | -6.52% |
| 2021-06-30 | $41.92 Million | +63.62% |
| 2020-06-30 | $25.62 Million | -8.73% |
| 2019-06-30 | $28.07 Million | -3.84% |
| 2018-06-30 | $29.20 Million | -4.97% |
| 2017-06-30 | $30.72 Million | -19.42% |
| 2016-06-30 | $38.13 Million | +1.53% |
| 2015-06-30 | $37.55 Million | -24.91% |
| 2014-06-30 | $50.01 Million | +132.18% |
| 2013-06-30 | $21.54 Million | +32.59% |
| 2012-06-30 | $16.24 Million | -51.23% |
| 2011-06-30 | $33.31 Million | +48.68% |
| 2010-06-30 | $22.40 Million | +78.22% |
| 2009-06-30 | $12.57 Million | +810.99% |
| 2008-06-30 | $1.38 Million | +14.90% |
| 2007-06-30 | $1.20 Million | -44.49% |
| 2006-06-30 | $2.16 Million | +150.03% |
| 2005-06-30 | $865.20K | +5878.85% |
| 2004-06-30 | $14.47K | +113.59% |
| 2003-06-30 | $6.78K | +409.78% |
| 2002-06-30 | $1.33K | -94.46% |
| 2000-06-30 | $24.00K | -84.63% |
| 1999-06-30 | $156.18K | -23.05% |
| 1998-06-30 | $202.97K | +13.50% |
| 1997-06-30 | $178.82K | -- |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Om… Read more